Monthly Archives: September 2023

Low-Income Nations Ill-Equipped for Cardiovascular Disease Fight

University of Birmingham Most healthcare facilities in many Low- and Middle-income Countries (LMICs) are unprepared to treat patients with cardiovascular diseases – despite these conditions leading to millions of people dying prematurely every year, a new study reveals. Experts analysed health survey data from eight LMICs across four World Health Organisation world regions to discover […]

Many low- and middle-income countries unprepared for the battle against cardiovascular disease, study finds

Credit: Pixabay/CC0 Public Domain Most health care facilities in many low- and middle-income countries (LMICs) are unprepared to treat patients with cardiovascular diseases—despite these conditions leading to millions of people dying prematurely every year, a new study reveals. Experts analyzed health survey data from eight LMICs across four World Health Organization world regions to discover […]

It’s time to take action to address blood cancers in California

Opinion Blood cancer cells, image by Lightspring by DR. WARREN FONG posted 09.22.2023 OPINION – California is facing an uphill battle against blood cancers. In 2022, the state led the nation in lymphoma diagnosis. The state is also experiencing staggering Leukemia numbers, and more than 40 percent of last year’s cases ended fatally. As a […]

Knee Infection: Symptoms, Causes, and Treatment

A knee infection can be caused by several different factors such as injury, surgery, or infection elsewhere in the body. An infected joint is considered an orthopedic emergency and typically requires quick and aggressive treatment to avoid potentially deadly complications. This article will explore the symptoms and causes of a knee infection as well as […]

WHO report highlights neglected health needs of children with developmental disabilities | The Highland County Press

A new report published this month by the World Health Organization (WHO) and UNICEF highlights the global prevalence of developmental disabilities among children and young people, shedding light on the urgent action needed to address disparities in their access to health care, health outcomes and exposure to social determinants such as poverty. The report estimates […]

Clinical trial to test immune modulation strategy for hospitalized

News Release Friday, September 22, 2023 Part of NIH’s STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms. A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial. The placebo-controlled study, part of the global clinical trials consortium known […]

Victim didn’t even realize best friend had stabbed him – until he saw the blood

#inform-video-player-1 .inform-embed { margin-top: 10px; margin-bottom: 20px; } #inform-video-player-2 .inform-embed { margin-top: 10px; margin-bottom: 20px; } SHARON – Devin Evans didn’t even realize his best friend had stabbed him during a drunken fight until after his friend left – and he realized the blood all over his house was coming from him. Evans, of Sharon, […]

How the national blood shortage is affecting Mississippi

The American Red Cross last week announced a nationwide blood shortage, which by default could take a toll on Mississippi. Newly-appointed Mississippi Blood Services President and CEO Christopher Swafford says their shelves are stocked for the time being. However, he notes that it only takes one incident for the supply to be consumed and that blood […]

Genetic Predictors of Ibrutinib-Related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia

Purpose: Patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib are at risk of developing cardiovascular side effects (CVSEs). The molecular determinants of CVSEs have not been fully elucidated. We interrogated genetic polymorphisms in the Bruton Tyrosine Kinase (BTK) signaling pathway for their association with ibrutinib-related CVSEs. Experimental Design: We conducted a retrospective/prospective observational pharmacogenetic […]